Diabetes & Coronary Disease
Sort by:
National Lipid Association
New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty Acids in Reducing Cardiovascular Risk
FEATURING
R. Preston Mason
- 17,616 views
- March 25, 2019
- 99
15th Annual Orange County Symposium for Cardiovascular Disease Prevention
LDL-C: Earlier and Lower Is Better and Safer?
FEATURING
Paul Rosenblit
- 3,467 views
- November 27, 2023
- 18
ACC 2023 Conference Coverage
ACC 2023: Failure to Treat With Pharmacologic GDMT After an MI: Opportunities Lost
FEATURING
Vicki Groo
- 1,345 views
- April 3, 2023
- 4
National Lipid Association
Colchicine: Now and What’s Next?
FEATURING
Christie Ballantyne
- 4,891 views
- October 11, 2023
- 24
Houston Methodist DeBakey Heart and Vascular Center
Aspirin for the Primary Prevention of Cardiovascular Disease: What Changed?
FEATURING
Michael Miedema
- 3,371 views
- January 25, 2022
- 24
Practical Ways to Achieve Targets in Diabetes Care
Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity
FEATURING
Steven Nissen
- 5,620 views
- July 26, 2023
- 61
13th Orange County Symposium for Cardiovascular Disease Prevention
SGLT2 inhibitors and GLP-1 agonists: Why Are They Important and Which Do I Choose?
FEATURING
Yehuda Handelsman
- 3,406 views
- January 27, 2022
- 15
National Lipid Association
Plant-based Diets for Improving Lipids
FEATURING
Kim Williams
- 3,509 views
- March 25, 2019
- 35
Inova Cherry Blossom Cardiovascular Symposium 2022
The Dangerous Intersection of Diabetes and Heart (and Kidney) Disease
FEATURING
Darren K. Mcguire
- 1,954 views
- August 2, 2022
- 13
Cardiometabolic Health Congress (CMHC)
ASCVD Risk Assessment and Prevention: Where Do We Stand Now?
FEATURING
Salim Virani
- 1,164 views
- July 23, 2022
- 13
Advances in Cardiovascular Disease Prevention
Paradigm Shifts: Understanding and Applying the Latest Lipid Guidelines
FEATURING
Andrew Freeman
- 1,336 views
- October 22, 2018
- 6
ASPC 2020 Virtual Summit on CVD Prevention
Integrating Imaging & Advanced Blood Testing for CVD Prevention/Management: How Do We Know If the Patient Is in Prediabetes Phase? Why Do Lipoproteins Become Atherogenic? What Is the Role of Non-Lifestyle Genetic Markers?
FEATURING
Arthur Agatston
- 483 views
- March 24, 2021
- 3
Practical Ways to Achieve Targets in Diabetes Care
Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target
FEATURING
Steven Nissen
- 4,147 views
- November 8, 2021
- 30
The Texas Heart Institute
Cardiometabolic Health: Actionable Prevention Strategies and New Care Models
FEATURING
David Aguilar
- 396 views
- September 7, 2023
- 4
Houston Methodist DeBakey Heart and Vascular Center
Should Cardiometabolic Protective Agents be the First Choice for Diabetic Patients?
FEATURING
Kershaw Patel
- 1,913 views
- November 15, 2022
- 8
Advances in Cardiovascular Disease Prevention
Lifestyle Management to Reduce Cardiovascular Risk
FEATURING
Andrew Freeman
- 1,562 views
- October 22, 2018
- 9
Georgia Heart Institute
Interview with Dr. Nehal Mehta, CCTA is the Future of Coronary Risk Stratification
FEATURING
Nehal N. Mehta
- 448 views
- June 21, 2022
- 4
National Lipid Association
Treatments for Maximizing Prevention of Microvascular Complications
FEATURING
Leah Wilson
- 411 views
- March 25, 2019
- 3
The Texas Heart Institute
Update of Diabetes Treatment: Overview of Current Trials and ADA Practice Recommendations
FEATURING
David Aguilar
- 776 views
- November 11, 2021
- 6
Piedmont Heart Institute
Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i
FEATURING
Jaime Burkle
- 1,738 views
- January 25, 2022
- 18
Cedars Sinai
What Diet Is Best for Cardiovascular Health?
FEATURING
Kim Williams
- 1,738 views
- February 4, 2022
- 14